Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Infection Control and Hospital Epidemiology|April 11, 2013
Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unitMichael G Schmidt, Hubert H Attaway Iii, Sarah E Fairey, et al.Journal of Bone and Joint Infection|May 27, 2020
Risk Factors for Fungal Prosthetic Joint InfectionTalha Riaz, Aaron J Tande, Lisa L Steed, et al.Current Microbiology|May 10, 2012
Characterization and control of the microbial community affiliated with copper or aluminum heat exchangers of HVAC systemsMichael G Schmidt, Hubert H Attaway, Silva Terzieva, et al.Medical Mycology Case Reports|January 17, 2014
A case of Exophiala oligosperma successfully treated with voriconazoleBassam H Rimawi, Ramzy H Rimawi, Meena Mirdamadi, et al.Journal of Clinical Microbiology|February 21, 2020
Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood CulturesSean X Zhang, Karen C Carroll, Shawna Lewis, et al.Antimicrobial Agents and Chemotherapy|July 29, 2009
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006Helio S Sader, Paul D Fey, Ajit P Limaye, et al.Journal of Clinical Microbiology|May 4, 2012
Sustained reduction of microbial burden on common hospital surfaces through introduction of copperMichael G Schmidt, Hubert H Attaway, Peter A Sharpe, et al.Infection Control and Hospital Epidemiology|April 11, 2013
Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unitCassandra D Salgado, Kent A Sepkowitz, Joseph F John, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrheaThomas J Louie, Jennifer Peppe, C Kevin Watt, et al.Antimicrobial Agents and Chemotherapy|July 28, 2006
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaJ John Weems, James P Steinberg, Scott Filler, et al.Pageof 4